checkAd

    INVESTOR ALERT  117  0 Kommentare Law Offices of Howard G. Smith Announces Investigation of PetMed Express, Inc. (PETS) on Behalf of Investors

    Law Offices of Howard G. Smith announces an investigation on behalf of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) investors concerning the Company’s possible violations of federal securities laws.

    On October 30, 2023, PetMed released its financial results for the second quarter of 2023, reporting net sales of $71 million, missing estimates by $5 million. Additionally, the Company disclosed that it “made a decision to suspend the quarterly dividend” to “invest the company's cash flow in projects and initiatives that we believe will yield higher returns.”

    On this news, PetMed's stock price fell $2.29, or 24.9%, to close at $6.89 per share on October 31, 2023, thereby injuring investors.

    If you purchased PetMed securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

    This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.


    The PetMed Express Stock at the time of publication of the news with a fall of -0,14 % to 7,28USD on Nasdaq stock exchange (09. November 2023, 15:50 Uhr).

    Diskutieren Sie über die enthaltenen Werte


    Business Wire (engl.)
    0 Follower
    Autor folgen

    INVESTOR ALERT Law Offices of Howard G. Smith Announces Investigation of PetMed Express, Inc. (PETS) on Behalf of Investors Law Offices of Howard G. Smith announces an investigation on behalf of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS) investors concerning the Company’s possible violations of federal securities laws. On October 30, 2023, PetMed …